NASDAQ: SLN
Silence Therapeutics PLC Stock Ownership - Who owns Silence Therapeutics?

Insider buying vs selling

Have Silence Therapeutics PLC insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SLN insiders and whales buy or sell their stock.

SLN Shareholders

What type of owners hold Silence Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Iain Ross0.03%39,942$424.98kInsider
Craig A. Tooman0.02%33,486$356.29kInsider
James Edegolightly0.01%15,000$159.60kInsider
Michael H. Davidson0.01%12,993$138.25kInsider
Steven J. Romano0.01%12,993$138.25kInsider
David Lemus0.01%7,527$80.09kInsider
Sirenl0.00%3,311$35.23kInstitution
Siren LLC0.00%3,311$35.23kInstitution
Tcgcro0.00%3,034$32.28kInstitution
Tcg Crossover Management LLC0.00%3,033$32.27kInstitution

1 of 3

SLN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLN0.02%0.09%
ENTX0.01%4.95%Net Buying
CTNM0.08%7.14%Net SellingNet Buying
NGNE0.09%89.43%Net SellingNet Selling
PBYI0.07%42.49%Net SellingNet Selling

Silence Therapeutics Stock Ownership FAQ

Who owns Silence Therapeutics?

Silence Therapeutics (NASDAQ: SLN) is owned by 0.02% institutional shareholders, 0.09% Silence Therapeutics insiders, and 99.90% retail investors. Iain Ross is the largest individual Silence Therapeutics shareholder, owning 39,942.00 shares representing 0.03% of the company. Iain Ross's Silence Therapeutics shares are currently valued at $424.98k.

If you're new to stock investing, here's how to buy Silence Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.